Real-time enrollment status for this locally recurrent skin squamous cell carcinoma clinical trial
Current Status
Recruiting
Checked: July 14, 2026 at 1:26 PM UTC
| NCT Number | NCT07042295 |
| Recruiting Status | Recruiting |
| Condition | Locally Recurrent Skin Squamous Cell Carcinoma |
| Phase | PHASE2 |
| Target Enrollment | 86 participants |
| Active Locations | 38 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | July 13, 2026 (Yesterday) |
As of July 14, 2026: Clinical trial NCT07042295 is currently recruiting participants. This phase2 study for locally recurrent skin squamous cell carcinoma is actively seeking new participants at 38 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07042295 is actively recruiting participants as of July 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 38 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07042295 was last updated Yesterday (July 13, 2026). HelloStudys verifies this status automatically.